NCT05624671 is a NA clinical trial of bupivacaine,fentanyl in 18-45 Range of Age, sponsored by Ataturk University.

Who is sponsoring NCT05624671?

NCT05624671 is sponsored by Ataturk University.

What drugs are being tested in NCT05624671?

Interventions in NCT05624671: bupivacaine,fentanyl.

What condition does NCT05624671 study?

NCT05624671 studies 18-45 Range of Age, Cesarean Section, Primigravid.

Is NCT05624671 still recruiting?

NCT05624671 is currently completed. Last updated 22 November 2022.

Last reviewed 2022-11-22 · How we verify

NCT05624671

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Is Elective Caesarean Sections for Predicting Post-spinal Hypotension Role of Overactive Bladder?

Completed NA Last updated 22 November 2022

What this trial tests

NA trial testing bupivacaine,fentanyl in 18-45 Range of Age in 143 participants. Completed in 30 December 2021.

Timeline

1 August 2019

Primary endpoint
30 December 2021

30 December 2021

Quick facts

Lead sponsor	Ataturk University
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	na
Design	single group
Masking	none
Primary purpose	screening
Enrollment	143
Start date	1 August 2019
Primary completion	30 December 2021
Estimated completion	30 December 2021
Sites	1 location across Turkey (Türkiye)

Drugs / interventions tested

bupivacaine,fentanyl

Conditions studied

18-45 Range of Age — all drugs for 18-45 Range of Age →
Cesarean Section — all drugs for Cesarean Section →
Primigravid — all drugs for Primigravid →

Sponsor

Ataturk University

Who can join

Adults 18 to 45, female only, with 18-45 Range of Age or Cesarean Section. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

It is to predict postspinal hypotension that may develop in patients diagnosed with overactive bladder who will undergo elective cesarean section under spinal-epidural anesthesia.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other Ataturk University trials

Trials by the same sponsor.

NCT07518537 — Bulk-Fill Composite Restorations: Clinical Evaluation · NA · not yet recruiting
NCT07241156 — Creative Drama on Gender Role Stress, Attitudes Toward Violence Against Women, and Aggression · NA · not yet recruiting
NCT07451418 — The Effect of Mindfulness Compassionate Living Training on Unwanted Pregnancies · NA · not yet recruiting
NCT07464548 — Effects of Stoma Education on Patients · NA · recruiting
NCT07375277 — Effects Of Biceps Transposition Without Tenotomy For Augmentation Of Massive Rotator Cuff Repairs · NA · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05624671 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Ataturk University
Last refreshed: 22 November 2022

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05624671.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing